Chronic Neuropathic Pain Due To Multiple Sclerosis Ms clinical trials

Explore recruiting chronic neuropathic pain due to multiple sclerosis ms clinical trials.

Also recruiting in Europe

Chronic Neuropathic Pain Due To Multiple Sclerosis Ms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Neuropathic Pain Due To Multiple Sclerosis Ms trials by city

Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Toronto Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Vancouver Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Montreal Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Calgary Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Edmonton Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Ottawa Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Winnipeg Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Quebec City Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Hamilton Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Kitchener Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in London Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Halifax Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in New York Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Los Angeles Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Chicago Chronic Neuropathic Pain Due To Multiple Sclerosis Ms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease